Tag: Valeant Pharmaceuticals International

May 1, 2017

Valeant Announces Debt Reduction

Valeant Pharmaceuticals International announced a $220 million reduction in its debt thanks to a skincare brand sale and an international...
April 26, 2017

Valeant's Subsidiary Earns FDA Clearance

Valeant Pharmaceuticals announced its owned subsidiary Bausch + Lomb received FDA clearance for Vitesse.
April 21, 2017

Valeant Sets Price for SILIQ Injection

Valeant Pharmaceuticals announced the official price for its SILIQ injection.